Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-02-11T12:04:47.238Z Has data issue: false hasContentIssue false
  • English
  • Français

Descriptive Epidemiology and Attributable Morbidity of Ventilator-Associated Events

Published online by Cambridge University Press:  10 May 2016

Michael Klompas ,
Ken Kleinman ,
Michael V. Murphy  and
for the CDC Prevention Epicenters Program
Michael Klompas*
Affiliation:
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts
Ken Kleinman
Affiliation:
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts
Michael V. Murphy
Affiliation:
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts
*
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

The Centers for Disease Control and Prevention implemented new surveillance definitions for ventilator-associated events (VAEs) in January 2013. We describe the epidemiology, attributable morbidity, and attributable mortality of VAEs.

Design.

Retrospective cohort study.

Setting.

Academic tertiary care center.

Patients.

All patients initiated on mechanical ventilation between January 1, 2006, and December 31, 2011.

Methods.

We calculated and compared VAE hazard ratios, antibiotic exposures, microbiology, attributable morbidity, and attributable mortality for all VAE tiers.

Results.

Among 20,356 episodes of mechanical ventilation, there were 1,141 (5.6%) ventilator-associated condition (VAC) events, 431 (2.1%) infection-related ventilator-associated complications (IVACs), 139 (0.7%) possible pneumonias, and 127 (0.6%) probable pneumonias. VAC hazard rates were highest in medical, surgical, and thoracic units and lowest in cardiac and neuroscience units. The median number of days to VAC onset was 6 (interquartile range, 4–11). The proportion of IVACs to VACs ranged from 29% in medical units to 42% in surgical units. Patients with probable pneumonia were more likely to be prescribed nafcillin, ceftazidime, and fluroquinolones compared with patients with possible pneumonia or IVAC-alone. The most frequendy isolated organisms were Staphylococcus aureus (29%), Pseudomonas aeruginosa (14%), and Enterobacter species (7.9%). Compared with matched controls, VAEs were associated with more days to extubation (relative rate, 3.12 [95% confidence interval (CI), 2.96–3.29]), more days to hospital discharge (relative rate, 1.46 [95% CI, 1.37–1.55]), and higher hospital mortality risk (odds ratio, 1.98 [95% CI, 1.60–2.44]).

Conclusions.

VAEs are common and morbid. Prevention strategies targeting VAEs are needed.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 5 , May 2014 , pp. 502 - 510
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention (CDC). Ventilator-Associated Event Protocol. Atlanta: CDC, 2013. http://www.cdc.gov/nhsn/acute-care-hospital/vae/index.html. Accessed February 25, 2013.Google Scholar
2. Magill, SS, Fridkin, SK. Improving surveillance definitions for ventilator-associated pneumonia in an era of public reporting and performance measurement. Clin Infect Dis 2012;54(3)378–380.Google Scholar
3. Klompas, M. Complications of mechanical ventilation: the CDC's new surveillance paradigm. N Engl J Med 2013;368(16): 1472–1475.Google Scholar
4. Klompas, M, Kleinman, K, Platt, R. Development of an algorithm for surveillance of ventilator-associated pneumonia with electronic data and comparison of algorithm results with clinician diagnoses. Infect Control Hosp Epidemiol 2008;29(l)31–37.Google Scholar
5. Klompas, M, Khan, Y, Kleinman, K, et al. Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS ONE 2011;6(3):el8062.Google Scholar
6. Klompas, M, Kleinman, K, Khan, Y, et al. Rapid and reproducible surveillance for ventilator-associated pneumonia. Clin Infect Dis 2012;54:370–377.Google Scholar
7. Klompas, M, Magill, S, Robicsek, A, et al. Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med 2012;40(12)3154–3161.Google Scholar
8. Prospero, E, Illuminati, D, Marigliano, A, et al. Learning from Galileo: ventilator-associated pneumonia surveillance. Am JRes-pir Crit Care Med 2012;186(12)1308–1309.Google Scholar
9. Hayashi, Y, Morisawa, K, Klompas, M, et al. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis 2013;56(4)471–477.CrossRefGoogle ScholarPubMed
10. Muscedere, J, Sinuff, T, Heyland, D, et al. The clinical impact and preventability of ventilator-associated conditions in critically ill mechanically ventilated patients. Chest 2013:144(5)1453–1460.Google Scholar
11. Elixhauser, A, Steiner, C, Harris, DR, Coffey, RM. Comorbidity measures for use with administrative data. Med Care 1998;36(1): 8-27.CrossRefGoogle ScholarPubMed
12. Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5)373–383.CrossRefGoogle ScholarPubMed
13. Hilbe, J. Negative Binomial Regression. 2nd ed. Cambridge: Cambridge University Press, 2011.CrossRefGoogle Scholar
14. Brown, AJ, Prescott, C. Applied Mixed Models in Medicine. Chicester: Wiley, 2006.Google Scholar
15. Little, R, Rubins, D. Statistical Analysis with Missing Data. New York: Wiley, 1987.Google Scholar
16. Dudeck, MA, Horan, TC, Peterson, KD, et al. National Healthcare Safety Network (NHSN) Report, data summary for 2010, device-associated module. Am J Infect Control 2011;39(10)798–816.Google Scholar
17. Cook, DJ, Walter, SD, Cook, RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129(6)433–440.Google Scholar
18. Koulenti, D, Lisboa, T, Brun-Buisson, C, et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009;37(8)2360–2368.Google Scholar
19. Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009-2010. Infect Control Hosp Epidemiol 2013;34(1)1–14.Google Scholar
20. Papazian, L, Thomas, P, Garbe, L, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am } Respir Crit Care Med 1995;152(6)1982–1991.Google Scholar
21. Torres, A, el-Ebiary, M, Padro, L, et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia: comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med 1994;149(2)324–331.CrossRefGoogle ScholarPubMed
22. Marquette, CH, Copin, MC, Wallet, F, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995;151(6)1878–1888.Google Scholar
23. Kirtland, SH, Corley, DE, Winterbauer, RH, et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997;112(2)445–457.CrossRefGoogle ScholarPubMed
24. Papazian, L, Autillo-Touati, A, Thomas, P, et al. Diagnosis of ventilator-associated pneumonia: an evaluation of direct examination and presence of intracellular organisms. Anesthesiology 1997;87(2)268–276.Google Scholar
25. Fabregas, N, Ewig, S, Torres, A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54(10)867–873.CrossRefGoogle ScholarPubMed
26. Klompas, M. Ventilator-associated events surveillance: a patient safety opportunity. Curr Opin Crit Care 2013;19(5)424–431.CrossRefGoogle ScholarPubMed